The overexpression of TYMS in our mesothelioma cohort, where pemetrexed is a key treatment, was probably due to the fact that most of the mesothelioma cases included were generally resistant to pemetrexed, and had overexpressed TS (45, 46). The gene discussed is TYMS; the disease is mesothelioma.